je.st
news
DEALTALK: Game may not be over for Royalty' Pharma's bid for Elan
2013-06-28 14:54:12| Biotech - Topix.net
The game may not yet be over for U.S investment firm Royalty Pharma in its months-long pursuit of Elan Corp. The Irish drugmaker earlier this month rejected a hostile bid by Royalty worth up to $8 billion.
Tags: for
game
bid
royalty
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||